ClinConnect ClinConnect Logo
Search / Trial NCT06847815

Corn Glycemic Index

Launched by UNIVERSITY OF FLORIDA · Feb 21, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Sweet Corn Glycemic Index

ClinConnect Summary

This clinical trial is looking at how different types of sweet corn and how they are processed can affect how our bodies digest them and respond in terms of blood sugar levels. The main goal is to find out the glycemic index, which is a measure of how quickly foods raise blood sugar after eating. Additionally, the study will also explore how eating sweet corn affects feelings of hunger and fullness.

To be eligible for this trial, participants should be between the ages of 65 and 75, be able to read and understand English, and be willing to eat specific amounts of glucose and sweet corn over several mornings. Participants will also need to provide small blood samples using a fingerstick, which is a quick and simple way to check blood sugar levels. However, individuals with certain health conditions that affect blood sugar, such as diabetes or metabolic syndrome, or those who are pregnant, cannot take part in this study. If you join, you can expect to help researchers learn more about sweet corn and its effects on our health!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Able to provide written consent in English
  • Willing to consume 50 g of glucose in less than 15 minutes (2 mornings)
  • Willing to consume around 250 to 350 g of sweet corn in 10 to 15 minutes (3 mornings)
  • Willing to provide 7 capillary blood samples by fingerstick (by fine lancet) during each 2-hour session
  • Exclusion Criteria:
  • Metabolic disease or condition affecting blood glucose, such as diabetes type 1 and 2, metabolic syndrome, or polycystic ovary syndrome
  • Baseline fasting blood glucose \> 100 mg/dL
  • Currently pregnant

About University Of Florida

The University of Florida, a leading research institution, is dedicated to advancing healthcare through innovative clinical trials. With a focus on enhancing patient outcomes and exploring new therapeutic avenues, the university leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct rigorous research across a variety of medical fields. Committed to ethical standards and patient safety, the University of Florida fosters collaboration among researchers, healthcare professionals, and community stakeholders to translate scientific discoveries into impactful clinical applications.

Locations

Gainesville, Florida, United States

Gainesville, Florida, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported